← Back to all trials
Active Not Recruiting
NCT05020496
Trem-1 and Ultraviolet Radiation-induced Immune Suppression
Conditions: Skin Diseases
Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: Yes
Phase: EARLY_PHASE1
Enrollment: 70
Sponsor: University of Alabama at Birmingham
Location: Whitaker Clinic Birmingham Alabama
Summary
The overall goal of this study is to determine novel mechanisms for ultraviolet light (UV)-induced suppression of the immune system in human subjects and to improve understanding of UV-induced skin carcinogenesis.
Eligibility Criteria
* Inclusion Criteria
* Patient age 18-35
* Patient able to understand requirements of the study and risks involved
* Patient able to sign a consent form
Exclusion Criteria:
* Patients Fitzpatrick IV-VI
* A recent history of vitiligo, melasma, and other disorders of pigmentation with the exception of post inflammatory hyperpigmentation
* Patients with eczema, psoriasis, and contact dermatitis
* A known history of photosensitivity disorders
* A known history of melanoma or non-melanoma skin cancers
* Those planning on going to the tanning parlors
* Using any of the photosensitizing medication
* A woman who is lactating, pregnant, or planning to become pregnant
* Patient planning on exposing the irradiated or control areas to the sun
* Patients with organ transplantation, an immunodeficiency disorder or the use of an immunosuppressive drug
Source: ClinicalTrials.gov (NCT05020496). StuddyBuddy aggregates publicly available trial information.